. Author manuscript; available in PMC: 2011 Mar 1.

Published in final edited form as: Bioanalysis. 2010 May 1;2(5):907–918. doi: 10.4155/bio.10.46

Table 1. Recognition of different cancer cell lines by aptamers selected for adenocarcinoma.

Cancer	Cell lines	S1	S6	S11e	S15
Adenocarcinoma (NSCLC)	A549	+++	++++	++++	++++
Large cell carcinoma (NSCLC)	HLAMP	+	++	+++	++
Large cell carcinoma (NSCLC)	NCI-H460	+	++	+++	++
Large cell carcinoma (NSCLC)	NCI-H299	0	+	+	+
Squamous carcinoma (NSCLC)	NCI-H520	0	0	+	0
Squamous carcinoma (NSCLC)	NCI-H157	0	0	++	0
Small-cell lung cancer	NCI-H446	0	0	++	0
Human cervical carcinoma	HeLa	0	0	0	0
Human breast carcinoma	MCF7	0	0	0	0
Hepatocellular carcinoma	HepG2	+	++	+++	++

Percentage: 0(<15%); +(10–35%); ++(35–60%); +++(60–85%); ++++(>85%).

NSCLC: Non-small-cell lung cancer.

Data from [21].